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A BST R A C T   
One of the first examples of musculoskeletal tissue engineering is autologous chondrocyte implantation 
(ACI).The first patient with a cartilage lesion was operated  with ACI in 1987 and at that time suspension 
implantation was used. Today, we use the third generation of ACI where scaffolds are employed to support 
redifferentiation and neocartilage formation in vitro and further maturation in vivo after implantation to treat the 
cartilage defects. 
A great deal of information is still needed to clinically improve cartilage production. Variables such us the cell 
seeding density, the cell culture media formulation, the degree of redifferentiation and the material and 
biological properties of the scaffold used remain to be investigated further. 
In the work reported in paper I we aimed to elucidate whether mesenchymal stem cells (MSC:s) are better than 
committed chondrocytes in producing cartilage in vitro, whether the co-culture of  MSC:s and chondrocytes play 
a role in enhancing cartilage production in vitro and if different biomaterials affect the differentiation capacity in 
vitro.  
The effect of the cell seeding concentration was evaluated in paper 2 by culturing human adult chondrocytes in 
chitosan scaffolds. After 14 and 28 days in a 3D culture, the constructs were assessed for collagen, 
glycosaminoglycans and DNA content. The mechanical properties of the constructs were determined using a 
dynamic oscillatory shear test. 
In paper I I I we studied whether the degree of redifferentiation of chondrocytes in in vitro cultured scaffolds had 
an effect on the neocartilage formation after implantation. It was studied whether redifferentiation of the 
chondrocytes was accomplished by recapitulating the signaling pattern used by chondrocytes during fetal 
development.  
In paper I V  we tried to determine the effect of different culture conditions on the in vivo chondrogenic capacity 
and integration properties of human tissue engineered chondrocyte constructs.  
In paper V  we evaluated the biomimetic properties of different materials. Materials with good biomimetic 
properties may influence the initial phases of tissue regeneration by inducing a strong migration of cells into the 
pores of the scaffold. 
Mater ials and M ethods  
MSC:s and human adult and pig chondrocytes were cultured in different materials in order to prove the different 
hypotheses. The chondrocyte differentiation in vitro and in vivo was evaluated using real time PCR to asses the 
expression of different genes. The total amount of collagen and proteglycans was determined biochemically. 
Inmunohistochemistry and different histological scores were used to evaluate the presence of cartilage specific 
proteins and to semiquantify the histological aspect of tissue engineered constructs after in vitro or in vivo 
evaluation. A novel transmigration assay was designed to evaluate the biomimetic properties of different 
biomaterials. To evaluate the in vivo chondrogenic potential, tissue engineered constructs produced in vitro were 
subcutaneously implanted in nude mice or into cartilage defects in human osteochondral plugs.  
Results  
Related to the number of chondrocytes used, coculture with MSC:s led to a strong increase in collagen type IX 
mRNA expression, an indicator for long-term stability of cartilage. Chondrocytes had better redifferentiation 
potential as compared to MSC:s. Tissue glue Tisseel® provided slightly better chondrogenic conditions than 
Tissue Fleece®. 
We determined that concentrations of 12?25 million cells/cm3 are needed in a chitosan scaffold to increase the 
matrix production and mechanical properties of human adult chondrocytes under static conditions. 
We were able to determine that the in vitro chondrogenesis in scaffolds induce a signalling pattern similar to the 
one seen in fetal development. Furthermore the results indicates that redifferentiation of in vitro expanded 
articular chondrocytes is needed at the time of implantation for neocartilage formation. However, 14 days of 
preculture in vitro used clinically today might be reduced. 
Conclusion 
 It is possible to significantly improve cartilage repair by using the right amount of cell concentration in seeded 
scaffolds, chondrogenic cells co-cultured and by choosing the right type of biomimetic scaffolding material. The 
future of cartilage repair lies in further development of suitable materials and good quality cells expanded under 
the most ideal conditions.   
